FDA approves Tresiba, Ryzodeg for diabetes treatment
September 29, 2015
Permalink
Health

FDA approves Tresiba, Ryzodeg for diabetes treatment

Novo Nordisk’s Tresiba (insulin degludec injection) has been approved in the US and is the…

Continue Reading →

FDA approves two new diabetes drugs
September 29, 2015
Permalink
Health

FDA approves two new diabetes drugs

Two new diabetes treatments, Tresiba (insulin degludec injection) and Ryzodeg (insulin degludec/insulin aspart injection), have…

Continue Reading →

Advertisement

FDA clears Novo’s Tresiba and Ryzodeg
September 26, 2015
Permalink
Health

FDA clears Novo’s Tresiba and Ryzodeg

On 26 March 2015, Novo Nordisk announced the decision to submit the class II resubmissions…

Continue Reading →

FDA approves two new diabetes drug treatments
September 26, 2015
Permalink
Health

FDA approves two new diabetes drug treatments

“Since 1923, Novo Nordisk has been committed to advancing insulin therapy for patients with diabetes,…

Continue Reading →

FDA Approves Diabetes Drugs
September 25, 2015
Permalink
Health

FDA Approves Diabetes Drugs

The agent also preferred our Ryzodeg, an shot that puts together Tresiba plus a fast-acting…

Continue Reading →